Mangalam Drugs And Organics Limited — Others, 17-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Mangalam Drugs and Organics Limited has announced a board meeting to discuss the compliance certificate received from MUFG Intime India Private Limited for the quarter ended December 31, 2024. This certificate confirms the acceptance and processing of securities for dematerialization, with no requests received from shareholders during the quarter. This update reinforces operational compliance and reflects efficient management of shareholder requests. Investors may view this as a positive outlook, indicating the company's commitment to regulatory adherence and smooth operational procedures, which could enhance investor confidence in ongoing governance practices.